{"slug":"vip-statins","verification":{"valid":true,"entries":5,"head":"6431f425e0e21d62ad74427dc6d1d175587b2d1a15ee777de7f1dd76eea9fd79"},"count":5,"sources":[{"id":"s1","type":"review","url":"https://www.sciencedirect.com/science/article/abs/pii/S0002914905021387","title":"Statins, Cardiovascular Disease, and Drug Safety","quote":"Recent clinical trial data suggest that aggressive low-density lipoprotein cholesterol lowering with statins reduces cardiovascular events.","summary":"Overview of statin mechanism and safety data.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:17:41.314Z","link_status":"http_400","quote_status":"unverified","prev":"genesis","hash":"c661ba20e75f1972caec22c2128deca262a2c0f2dcc2ec3e8fd5c9ef7784ac97"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/12885101/","title":"Statin-associated memory loss: analysis of 60 case reports","quote":"However, available prospective studies show no cognitive or antiamyloid benefits for any statin. In addition, case reports raise the possibility that statins, in rare cases, may be associated with cognitive impairment, though causality is not certain.","summary":"Analysis separating case reports from trial evidence on statin cognitive effects.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:17:41.314Z","link_status":"ok","quote_status":"verified","prev":"c661ba20e75f1972caec22c2128deca262a2c0f2dcc2ec3e8fd5c9ef7784ac97","hash":"65ecbfd67d4a5b65d9169cf8491b81b83bd553ea59407a48b42bd96bedfc59d4"},{"id":"s3","type":"pubmed","url":"https://www.survivingmold.com/docs/VIP_published_3_2013.pdf","title":"Vasoactive intestinal polypeptide (VIP) corrects chronic inflammatory response syndrome (CIRS)","quote":"The trial showed that VIP therapy safely 1) reduced refractory symptoms...","summary":"Open-label human data on nasal VIP in CIRS patients.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:17:41.314Z","link_status":"ok","quote_status":"unverified","prev":"65ecbfd67d4a5b65d9169cf8491b81b83bd553ea59407a48b42bd96bedfc59d4","hash":"f4627ec2de332bfa57f4c00ba3e884b34d0f45dd7586251f8232466c976c7d7c"},{"id":"s4","type":"review","url":"https://www.hopkinsarthritis.org/arthritis-news/vasoactive-intestinal-peptide-vip-prevents-experimental-arthritis-news-summary-from-johns-hopkins-arthritis/","title":"Vasoactive intestinal peptide (VIP) prevents experimental arthritis","quote":"Mice treated with VIP showed delayed onset, lower incidence and decreased severity of CIA in comparison with placebo-treated arthritic mice.","summary":"Preclinical arthritis model results for VIP.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:17:41.314Z","link_status":"ok","quote_status":"verified","prev":"f4627ec2de332bfa57f4c00ba3e884b34d0f45dd7586251f8232466c976c7d7c","hash":"e52a6cb3d10e1b581d44196a317b2c96f48f18c5259798cd70264fa4a869558b"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/3687785/","title":"Cardiovascular effects of vasoactive intestinal peptide in man","quote":"VIP infusion caused sustained vasodilatation and decreased total peripheral resistance and mean arterial pressure by 30 and 12%, respectively.","summary":"Human infusion study documenting VIP vasodilatory actions.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:17:41.314Z","link_status":"ok","quote_status":"verified","prev":"e52a6cb3d10e1b581d44196a317b2c96f48f18c5259798cd70264fa4a869558b","hash":"6431f425e0e21d62ad74427dc6d1d175587b2d1a15ee777de7f1dd76eea9fd79"}]}